Funding Announcements

"Dex’s mission is to empower individuals to do meaningful work byconnecting them with opportunities that align with their ambitions and values. Our aim is to redefine how talent and opportunity connect, globally. We’re working at the forefront of what is possible when it comes to conversational, generative AI and we’re thrilled to have some of the best AI investors in the world helping us to achieve that vision."

"The investment we’ve received so far reinforces the strength of our business model and has accelerated our progress. Opening our Series A investment round to the public for the first time goes one step further and represents a major milestone for us as a company."

"Spotlight Pathology represents exactly the type of highly innovative company that Deepbridge is privileged to invest in. We initially supported the team through our Seed Enterprise Investment Scheme (SEIS), and are now pleased to back them again through our EIS fund, alongside EHE and Lyva Labs. We look forward to supporting the team as they scale in the exciting field of digital pathology."

"Astrato is the execution layer of the modern data stack. It connects directly to the cloud and gives teams a unified space to explore, act, and collaborate on data without duplication, IT bottlenecks, or licensing friction. Unlike legacy BI vendors pushing continuous price hikes, our usage-based model means customers only pay for what they consume, making Astrato accessible for both lean startups and global enterprises."

"We are creating a mutually beneficial partnership. The investment will enable Addionics to accelerate the development and commercialization of its unique technology for current collectors. Our process know-how, materials science knowledge and global reach complement Addionics’ novel technology and entrepreneurial spirit. Equally important, the partnership contributes to advancing sustainability."